BioSurgery

Reduce View Slide Up Enlarge View Slide Down

Achieving Rapid Hemostasis

FLOSEAL Hemostatic Matrix is a proprietary combination of two independent hemostasis promoting agents.1,2

Stops bleeding fast (2 minutes median time to hemostasis), at the site of action.1

Consistent and Effective Hemostasis1


Click to enlarge image

  • Stops bleeding 97% of the time within 6-10 minutes [first lesion; per protocol analysis]1
  • Proven to control bleeding from oozing to spurting1
  • FLOSEAL was efficacious 89% of the time in fully-heparinized patients undergoing cardiac surgery1,2
  • Effective on both hard and soft tissue3
  • FLOSEAL granules expand approximately 20% within about 10 minutes, giving predictable control during and after surgery1

The Science Behind FLOSEAL Hemostatic Matrix

  • Only FLOSEAL provides a proprietary combination of two independent hemostasis promoting agents.1,2
    • The gelatin granules swell to produce a tamponade effect4
    • High concentrations of human thrombin convert fibrinogen into fibrin monomers accelerating clot formation4


Click to enlarge image

Controls Bleeding from Oozing to Spurting1


Click to enlarge image

Easy to Use

  • Convenient kit contains all the items necessary for use, including human thrombin, and can be prepared in as short as 2 minutes3
  • FLOSEAL can be applied focally at the target site of bleeding*1

*Please refer to the Instructions For Use for complete application techniques

Works in a Wide Range of Bleeding Scenarios

  • Effective on both hard and soft tissue3
  • Clinically proven to control bleeding in heparinized cardiac patients1,2
  • Works on wet, actively bleeding tissue1
  • Conforms to irregular wound surfaces4

Safety Profile

  • Bio-resorbable1
  • Biocompatible/pH neutral14
  • Latex free1

Learn more about Baxter's commitment to Pathogen Safety.
(Pathogen Safety Monograph)

FLOSEAL is indicated in surgical procedures (other than ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

FLOSEAL Instructions For Use

Important FLOSEAL Risk Information

Order Information

Order # Description
1501825 FLOSEAL [Hemostatic Matrix] 5 mL, 6 pack
1501824 FLOSEAL [Hemostatic Matrix], 10 mL, 6 pack
934208    Curved Applicator Tip 8 cm
934210     Curved Applicator Tip 10 cm
1500181 Endoscopic Applicator, Sterile/Single Use (pack of 6)
934055 FLOSEAL Endoscopic Applicator (Reusable)
1502186   Malleable & Trimmable Applicator Tips 14 cm (case of 6)

 

References:

  1. FLOSEAL Hemostatic Matrix Instructions For Use. Hayward, CA: Baxter Healthcare Corporation; 0710217, May 2010.
  2. Oz MC, Cosgrove DM 3rd, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. 2000;69:1376-1382.
  3. Renkens KL Jr, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. 2001;26:1645-1650.
  4. Oz MC, Rondinone JF, Shargill NS. FloSeal Matrix: new generation topical hemostatic sealant. 2003;18:486-493.
  5. SURGICEL Prescribing Information. Somerville, NJ: J&J Wound Management. 2007. 
  6. SURGIFLO Instructions for Use. Somerville, NJ: J&J Wound Management. Sept. 2009.
  7. SURGIFOAM Prescribing Information,  Somerville, NJ: J&J Wound Management, 2008. 
  8. GELFOAM Sponge Prescribing Information. New York, NY: Pfizer. Sept. 2008.
  9. Data on File, Baxter Healthcare Corporation.
  10. EVICEL Prescribing Information. Somerville, NJ: J&J Wound Management. Feb. 2008.
  11. TISSEEL [Fibrin Sealant] full Prescribing Information, Jan. 2010.
  12. ARISTA Instructions For Use. Minneaopolis, MN: Medafor, Inc. 2007.
  13. GELFOAM PLUS Instructions for Use. Hayward, CA: Baxter International Inc; May 2009.
  14. Data on File, Baxter Healthcare Corporation.

Baxter and Floseal are trademarks of Baxter International, Inc.
All other products or trademarks appearing herein are property of their respective owners.